Nucleix announces $22 million in funding, advancements in lung cancer detection program
The Israeli company develops non-invasive, DNA methylation-based cancer screening tests for early-stage and recurring cancer detection
Source: calcalistech.com
Stay updated with breaking news from Epicheck Next Generation Sequencing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Israeli company develops non-invasive, DNA methylation-based cancer screening tests for early-stage and recurring cancer detection